Cite
Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry.
MLA
Jonghak Woo, et al. “Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry.” Journal of Open Innovation, vol. 5, no. 3, Sept. 2019, pp. 1–19. EBSCOhost, https://doi.org/10.3390/joitmc5030045.
APA
Jonghak Woo, Eungdo Kim, Tae-Eung Sung, Jongtaik Lee, Kwangsoo Shin, & Jeonghee Lee. (2019). Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry. Journal of Open Innovation, 5(3), 1–19. https://doi.org/10.3390/joitmc5030045
Chicago
Jonghak Woo, Eungdo Kim, Tae-Eung Sung, Jongtaik Lee, Kwangsoo Shin, and Jeonghee Lee. 2019. “Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry.” Journal of Open Innovation 5 (3): 1–19. doi:10.3390/joitmc5030045.